about
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenc...
Read More
112.92
-1.23
(-1.08%)
575.6K
XNYS Volume
XNYS 09 Jan, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Glaukos Corp is on 13 Jan 2026 for the purpose of J.P. Morgan Healthcare Conference
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Glaukos Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..